Big Pharma's billion-dollar scramble to invest in start-ups to fuel innovation

March 28, 2018 -
7 months ago
In the media
Companies leading the league are those developing creative approaches to the R&D productivity crisis with all kinds of early stage collaborations. At J&J the company is building a network of incubators known as JLABS to get a window on early stage breakthroughs. It operates shared workspaces and labs with chemistry, biotechnology and prototyping equipment for local scientists and entrepreneurs to use. Launched in 2012, it has eight incubators, in cities such as San Francisco, Boston, San Diego, Houston, Toronto and Beerse, Belgium. It plans to open two more — one in New York in June, and another in Shanghai next year.

Related content